Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06444919
PHASE4

Capsaicin in Digital Osteoarthritis Versus Control

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

The objective of this multicentric, randomized controlled double-blind clinical trial is to demonstrate the efficacy of transdermal application of capsaicin in patients with painful digital osteoarthritis with a neuropathic pain component. Participants will receive either a transdermal patch of capsaicin 179 mg (8%) or the control treatment (capsaicin 0.04%). Researchers will compare the intensity of pain in the fingers at day 60 in the capsaicin 8% group versus capsaicin 0.04% (control arm)

Official title: Capsaicin in Digital Osteoarthritis Versus Control : a Randomized Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-03-07

Completion Date

2028-01-01

Last Updated

2025-03-13

Healthy Volunteers

No

Interventions

DRUG

Capsaicin 179 Mg Cutaneous Patch

patch application for 30 minutes on the painful fingers.

DRUG

Capsaicine low dose 0.04 %

patch application for 30 minutes on the painful fingers. the low-dose patch has a similar appearance to the active patch. It allows you to keep the blind, because it also causes reactions at the capsaicin application site (erythema, burning).

Locations (4)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

HCL Hôpital Edouard Herriot

Lyon, France

AP-HP Hôpital Saint-Antoine

Paris, France

CHU de Saint-Etienne

Saint-Etienne, France